ISSN: 2381-8727

International Journal of Inflammation, Cancer and Integrative Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Int J Inflam Cancer Integr Ther 2024, Vol 11(2): 272

Engineering Immune Cells for Precision Immunotherapy: Promises and Pitfalls

Xiang Liu*
School of Pharmacy, Nanjing University of Chinese Medicine, China
*Corresponding Author : Xiang Liu, School of Pharmacy, Nanjing University of Chinese Medicine, China, Email: xiang@njucm.edu.cn

Received Date: Apr 01, 2024 / Published Date: Apr 29, 2024

Abstract

Precision immunotherapy has revolutionized the landscape of cancer treatment by harnessing the power of engineered immune cells to target and eliminate tumors with remarkable specificity. This article explores the promises and pitfalls of engineering immune cells for precision immunotherapy, highlighting key advancements, challenges and future directions in this rapidly evolving field.

Citation: Xiang L (2024) Engineering Immune Cells for Precision Immunotherapy:Promises and Pitfalls. Int J Inflam Cancer Integr Ther, 11: 272.

Copyright: © 2024 Xiang L. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top